Similar articles

• Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.

  Muller F, Cugy E, Ducerf C, Delleci C, Guehl D, Joseph PA, Burbaud P, Dehail P. Muller F, et al. Clin Rehabil. 2012 Feb;26(2):174-9. doi: 10.1177/0269215511412799. Epub 2011 Sep 21. Clin Rehabil. 2012. PMID: 21937525
• Time course analysis of the effects of botulinum toxin type a on elbow spasticity based on biomechanic and electromyographic parameters.

  Lee HM, Chen JJ, Wu YN, Wang YL, Huang SC, Piotrkiewicz M. Lee HM, et al. Arch Phys Med Rehabil. 2008 Apr;89(4):692-9. doi: 10.1016/j.apmr.2007.08.166. Arch Phys Med Rehabil. 2008. PMID: 18374000
• Local botulinum toxin type A injections in the treatment of spastic toes.

  Suputtitada A. Suputtitada A. Am J Phys Med Rehabil. 2002 Oct;81(10):770-5. doi: 10.1097/00002060-200210000-00009. Am J Phys Med Rehabil. 2002. PMID: 12362118 Clinical Trial.
• A Delphi-Based Consensus Statement on the Management of Anticoagulated Patients With Botulinum Toxin for Limb Spasticity.

  Boulias C, Ismail F, Phadke CP, Bagg S, Bureau I, Charest S, Chen R, Cheng A, Ethans K, Fink M, Finlayson H, Gulasingam S, Guo M, Haziza M, Hosseini H, Khan O, Lang M, Lapp T, Leckey R, Li Pi Shan R, Liem N, Lo A, Mason M, McNeil S, McVeigh S, Miller T, Mills PB, Naud P, O'Connell C, Petitclerc M, Prevost J, Reebye R, Richardson D, Satkunam L, Sharma S, Short C, Sirois G, Unarket M, Wein T, Wilkins K, Winston P. Boulias C, et al. Arch Phys Med Rehabil. 2018 Nov;99(11):2183-2189. doi: 10.1016/j.apmr.2018.04.023. Epub 2018 May 24. Arch Phys Med Rehabil. 2018. PMID: 29803825
• Botulinum neurotoxin in muscle overactivity.

  Esquenazi A. Esquenazi A. J Head Trauma Rehabil. 2005 Nov-Dec;20(6):563-7. doi: 10.1097/00001199-200511000-00007. J Head Trauma Rehabil. 2005. PMID: 16304491 Review. No abstract available.